Phase 1 of the programme intends to support early stage concepts and prototypes with up to £150,000 in funding over 6-12 months. Phase 2 is aimed to develop and evaluate prototypes and generate early clinical safety and efficacy data.
The programme has 4 phases, in which 42 suppliers and projects have joined. 5 AI projects have joined phase 3 to support testing and to develop evidence to support further adoption. 10 suppliers have joined the final phase to support wider adoption.
The NHS AI Lab tests and helps scale AI products and is backed by £250m in funding from the Department for Health and Social Care. The Award is run by the Accelerated Access Collaborative in partnership with NHSX and the National Institute for Health Research. It will make £140 million available over three years to accelerate the testing and evaluation of AI technologies which meet the strategic aims of the NHS Long Term Plan.